Europlaz Debuts New Innovation to Improve Neonatal Care 

UK-based company, Europlaz, has developed a new medical innovation to help improve neonatal care and save the lives of more babies born prematurely or in distress.

This innovation has an integrated ‘sidestream’ CO₂ sampling port that is joined to the side of its existing neonatal flow sensor. This addition allows clinicians to follow the correct protocols of using both lung protective volume control and CO₂ monitoring, giving the baby the best chance of survival and limiting the possibility of longer-term conditions, such as cerebral palsy or lung disease.

Europlaz is heavily investing in production for its new neonatal flow sensor, with a new robotic welder arriving shortly. 

This is the central element of a modern production cell that uses vision-controlled micro-robotic wire welding to deliver highly consistent sensor quality, performance, and reliability.

Frede Jensen, Product Development Manager at Europlaz commented: “This latest piece of equipment is very impressive, with the robot capable of welding a 13-micron precious metal wire (which is 1/3 of the thickness of a human hair) to a surface smaller than a pin head with 5-micron precision… We can also increase capacity, with the genuine expectation that we can supply 500,000 sensors every year.”

Chelmsford-based Europlaz has been developing this innovation for years and believes now is the time for ventilator manufacturers to consider switching to this neonatal flow sensor aims to save lives, reduce costs to the NHS, and avoid expensive litigation.